Clinical Trial

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

Study acronym: SAVE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This randomized phase III trial studies short course vaginal cuff brachytherapy to see how well it works compared with standard of care vaginal cuff brachytherapy in treating participants with stage I-II endometrial cancer. Short course vaginal cuff brachytherapy, also known as internal radiation therapy, uses (over a shorter period) radioactive material placed directly into or near a tumor in the upper portion of the vagina to kill tumor cells. After completion of cohort 1 (108 participants), the protocol was expended to add a second cohort of 80 additional participants, and re-opened study recruitment.
Protocol Amendment History 21 amendments
This ClinicalTrials.gov record has been amended 21 times since 2018-02-02; most recent amendment 2025-11-25.
Status change: Active, Not Recruiting → Recruiting 2024-02-28
Status change: Recruiting → Active, Not Recruiting 2021-12-16
Trial Details
NCT Number NCT03422198
Lead Sponsor University of Utah
Collaborators: Huntsman Cancer Institute
Conditions Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Uterine Corpus Carcinosarcoma +1 more
Enrollment 188 participants
Start Date 2018-02-02
Primary Completion 2026-11-30 (estimated)
Study Completion 2029-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-12